vs

Side-by-side financial comparison of Navan, Inc. (NAVN) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $194.9M, roughly 1.0× Navan, Inc.). REPLIGEN CORP runs the higher net margin — 6.7% vs -115.6%, a 122.3% gap on every dollar of revenue. REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-1.9M).

Navan, Inc. is an American corporate travel and expense management company headquartered in Palo Alto, California. Founded in May 2015 by Ariel Cohen and Ilan Twig, Navan offers an integrated platform combining travel booking, corporate-issued payment cards, expense reporting, and analytics for businesses worldwide.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

NAVN vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.0× larger
RGEN
$197.9M
$194.9M
NAVN
Higher net margin
RGEN
RGEN
122.3% more per $
RGEN
6.7%
-115.6%
NAVN
More free cash flow
RGEN
RGEN
$19.5M more FCF
RGEN
$17.6M
$-1.9M
NAVN

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
NAVN
NAVN
RGEN
RGEN
Revenue
$194.9M
$197.9M
Net Profit
$-225.4M
$13.3M
Gross Margin
70.7%
52.5%
Operating Margin
-40.6%
9.0%
Net Margin
-115.6%
6.7%
Revenue YoY
13.6%
Net Profit YoY
-483.6%
143.9%
EPS (diluted)
$-4.58
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NAVN
NAVN
RGEN
RGEN
Q4 25
$194.9M
$197.9M
Q3 25
$188.8M
Q2 25
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
NAVN
NAVN
RGEN
RGEN
Q4 25
$-225.4M
$13.3M
Q3 25
$14.9M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
NAVN
NAVN
RGEN
RGEN
Q4 25
70.7%
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
NAVN
NAVN
RGEN
RGEN
Q4 25
-40.6%
9.0%
Q3 25
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
NAVN
NAVN
RGEN
RGEN
Q4 25
-115.6%
6.7%
Q3 25
7.9%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
NAVN
NAVN
RGEN
RGEN
Q4 25
$-4.58
$0.24
Q3 25
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NAVN
NAVN
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$809.1M
$767.6M
Total DebtLower is stronger
$206.6M
$542.2M
Stockholders' EquityBook value
$1.2B
$2.1B
Total Assets
$1.8B
$2.9B
Debt / EquityLower = less leverage
0.17×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NAVN
NAVN
RGEN
RGEN
Q4 25
$809.1M
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
NAVN
NAVN
RGEN
RGEN
Q4 25
$206.6M
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NAVN
NAVN
RGEN
RGEN
Q4 25
$1.2B
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
NAVN
NAVN
RGEN
RGEN
Q4 25
$1.8B
$2.9B
Q3 25
$2.9B
Q2 25
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
NAVN
NAVN
RGEN
RGEN
Q4 25
0.17×
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NAVN
NAVN
RGEN
RGEN
Operating Cash FlowLast quarter
$-1.3M
$25.7M
Free Cash FlowOCF − Capex
$-1.9M
$17.6M
FCF MarginFCF / Revenue
-1.0%
8.9%
Capex IntensityCapex / Revenue
0.3%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NAVN
NAVN
RGEN
RGEN
Q4 25
$-1.3M
$25.7M
Q3 25
$48.1M
Q2 25
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
NAVN
NAVN
RGEN
RGEN
Q4 25
$-1.9M
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
NAVN
NAVN
RGEN
RGEN
Q4 25
-1.0%
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
NAVN
NAVN
RGEN
RGEN
Q4 25
0.3%
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
NAVN
NAVN
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NAVN
NAVN

Usage Based Revenue$179.9M92%
Subscription Revenue$15.0M8%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons